Cirata plc

Cirata did not report revenue or EPS in this update. Closing ACV was GBP 5.3 million, up from GBP 4.9 million at the start of the quarter, with GBP 0.4 million of net new ACV driven by renewals and expansion within the existing customer base; no new logos were closed. Gross proceeds from the fundraise totaled $7.2 million, and the unaudited cash balance as of June 30 was GBP 2.6 million, with cash plus short-term receivables of GBP 2.8 million. Q2 net cash consumption was GBP 2.1 million, and overheads were GBP 3.2 million, which management said fits within its FY 2026 annualized GBP 12 million to GBP 13 million range. Management reaffirmed its outlook from January 14, 2026, including a target of cash flow breakeven for FY 2026.

Stephen Kelly framed the fundraise as a key foundation for the next phase, saying it strengthens the balance sheet and gives Cirata room to invest with discipline in go-to-market execution, pipeline conversion, and product scale. He was candid that the quarter was disappointing because no new logos closed, but said the business now has a fully resourced sales team, a 40% larger pipeline, and better customer-facing infrastructure to convert opportunities as the year progresses. His tone was confident but still execution-focused, emphasizing a shift from prior 'heroic selling' to a more repeatable model.

No separate CFO spoke in the transcript; Stephen Kelly covered the financial commentary. He said the company raised $7.2 million gross and had GBP 2.6 million in unaudited cash at June 30, or GBP 2.8 million including short-term receivables. He also noted Q2 net cash outflow of GBP 2.1 million, overheads of GBP 3.2 million, and a cost base that remains more than 70% below the peak, while reaffirming FY 2026 cash flow breakeven. The message was that tighter spending plus the new capital should provide runway to pursue growth without losing cost discipline.

Analysts focused on three issues: why the fundraise was oversubscribed, why ACV growth came only from existing customers, and what supports the cash flow breakeven target. Management said the oversubscription showed both existing and new shareholders back the strategy, and that proceeds will fund disciplined investment in go-to-market. On the ACV shortfall, Kelly acknowledged the miss, pointed to lumpy enterprise sales cycles, and said the sales team only reached full strength in recent months. On breakeven, he said the combination of lower overheads, the strengthened balance sheet, and a larger, higher-quality pipeline gives him confidence.